These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1100915)
21. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung. Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467 [No Abstract] [Full Text] [Related]
22. Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel. Horton J; Mittelman A; Taylor SG; Jurkowitz L; Bennett JM; Ezdinli E; Colsky J; Hanley JA Cancer Chemother Rep; 1975; 59(2 Pt 1):333-40. PubMed ID: 125147 [TBL] [Abstract][Full Text] [Related]
23. Controlled study of CCNU and radiation therapy in malignant astrocytoma. Reagan TJ; Bisel HF; Childs DS; Layton DD; Rhoton AL; Taylor WF J Neurosurg; 1976 Feb; 44(2):186-90. PubMed ID: 173814 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of CCNU (NSC-79037) used for the prevention of CNS involvement in Burkitt's lymphoma. Ziegler JL; Magrath IT; Nkrumah FK; Perkins IV; Simon R Cancer Chemother Rep; 1975; 59(6):1155-6. PubMed ID: 769955 [No Abstract] [Full Text] [Related]
26. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719 [TBL] [Abstract][Full Text] [Related]
27. Phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in the treatment of brain tumors. Fewer D; Wilson CB; Boldrey EB; Enot JK Cancer Chemother Rep; 1972 Jun; 56(3):421-7. PubMed ID: 19051504 [TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma. DiBella NJ; Nelson RA; Norgard MJ Oncology; 1975; 32(2):82-5. PubMed ID: 815858 [TBL] [Abstract][Full Text] [Related]
29. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer. Waterfield WC; Tashima CK; Hortobagyi GN; Blumenschein GR; Buzdar AU; Burgess MA Cancer; 1978 Apr; 41(4):1235-9. PubMed ID: 638989 [TBL] [Abstract][Full Text] [Related]
31. Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva. Omura GA; Shingleton HM; Creasman WT; Blessing JA; Boronow RC Cancer Treat Rep; 1978 May; 62(5):833-5. PubMed ID: 350400 [No Abstract] [Full Text] [Related]
32. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals. Broder LE; Hansen HH Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488 [No Abstract] [Full Text] [Related]
33. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT; Siemann DW Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329 [TBL] [Abstract][Full Text] [Related]
34. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma. Laurent G; Atassi G; Hildebrand J Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049 [TBL] [Abstract][Full Text] [Related]
35. Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU). Waldbaur H; Kuschnir H; Engelmann U; Schmidt H; Schmack B Acta Neurochir (Wien); 1978; 42(1-2):103-8. PubMed ID: 696438 [TBL] [Abstract][Full Text] [Related]
36. Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glioma. Costanza M; Buechler M; Munzenreider J; Emami B; Mukherji B; Shucart W; Scott M; Nathanson L; Rudders R; Stein B; Post K; Piro A Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1589-92. PubMed ID: 231595 [No Abstract] [Full Text] [Related]
37. Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors. Robustelli della Cuna G; Paoletti P; Bernardo G; Knerich R; Butti G; Cuzzoni Q Neurosurgery; 1982 Sep; 11(3):408-11. PubMed ID: 6290930 [TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of advanced transitional cell carcinoma of the renal pelvis: report of 3 cases treated with vinblastine and chloroethyl-cyclohexyl-nitrosourea. von Eyben F; Mattsson W; Glifberg I; Lindholm CE J Urol; 1979 Mar; 121(3):367-8. PubMed ID: 430637 [TBL] [Abstract][Full Text] [Related]
39. Treatment of malignant gliomas in adults using a combination of adriamycine, VM 26 and CCNU: results of a type II trial. Pouillart P; Mathe G; Thy TH; Lheritier J; Poisson M; Huguenin P; Gautier H; Morin P; Parrot R Eur J Cancer (1965); 1977; 13(4-5):419-24. PubMed ID: 326555 [No Abstract] [Full Text] [Related]
40. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037). Einhorn LH; Livingston RB; Gottlieb JA Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]